Yearly Injection To Protect Against HIV? Gilead's Lenacapavir Shows Promise In Clinical Trial
A Lancet study shows promising results for an annual HIV prevention injection, lenacapavir. In Stage 1 trials, 40 HIV-negative participants had no significant side effects ...
Devdiscourse6d
Yearly HIV Injection Shows Promise in Prevention Efforts
A clinical trial published in The Lancet suggests that a yearly injection of lenacapavir, developed by Gilead Sciences, is ...